Immunology and Microbiology
Bacteriophage
100%
Biofilm
87%
IgA Nephropathy
57%
Pseudomonas aeruginosa
43%
B Cell
42%
Staphylococcus Aureus
40%
Escherichia coli
30%
COVID-19
28%
Severe Acute Respiratory Syndrome Coronavirus 2
28%
Immunoglobulin A
23%
Antimicrobial Resistance
17%
Antimicrobial Agent
16%
Abscess
14%
Complement Component 3
14%
Complement Component 4
14%
Normal Human
14%
Glycoprotein
14%
Acinetobacter
14%
Peritoneal Dialysis
14%
Femtosecond Laser
14%
Mortality Rate
14%
Creatinine Blood Level
14%
Klebsiella pneumoniae
14%
Microorganism
14%
Ferritin
14%
Complement
14%
Cell Population
14%
Antibacterial Activity
14%
Urea
14%
Leucine
14%
Urine Sampling
9%
Infectious Agent
8%
Bacterial Strain
8%
Titer
5%
Urinary Tract
5%
Microflora
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bacteriophage
57%
Staphylococcus Aureus
47%
Biological Marker
39%
Leucine
37%
Alpha2 Glycoprotein
37%
Prospective Cohort Study
28%
Acute Kidney Failure
28%
Pseudomonas aeruginosa
28%
SARS Coronavirus
22%
Tubular Dysfunction
19%
Kidney Injury
18%
Cystatin C
18%
Antimicrobial Resistance
17%
Creatinine
16%
Proteinuria
14%
Antiinfective Agent
14%
Observational Study
14%
Normal Human
14%
Driveline Infection
14%
Adult Respiratory Distress Syndrome
14%
Tonsillitis
14%
Klebsiella pneumoniae
14%
Acinetobacter
14%
Antibiotic Agent
14%
Microorganism
14%
Antimicrobial Agent
14%
Peritonsillar Abscess
14%
Biopolymer
14%
Antibiotics
12%
Syndrome
11%
Infectious Agent
9%
Deterioration
8%
Mortality Rate
8%
Ferritin
8%
Inflammation
6%
End Stage Renal Disease
6%
Enzyme-Linked Immunosorbent Assay
6%
Alginic Acid
5%
Neutrophil Gelatinase Associated Lipocalin
5%
Microflora
5%
Medicine and Dentistry
Immunoglobulin A Nephropathy
57%
Bacteriophage
40%
B Cell
28%
Tonsillitis
28%
Pseudomonas aeruginosa
28%
Staphylococcus Aureus
19%
Kidney Graft
18%
COVID-19
16%
Biological Marker
16%
Immunoglobulin A
16%
Antimicrobial Agent
16%
Renal Replacement Therapy
15%
Tonsillectomy
15%
Antiinfective Agent
15%
Antibiotics
15%
Prospective Cohort Study
14%
Acute Kidney Injury
14%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Leucine
14%
Alpha2 Glycoprotein
14%
Disease Course
14%
Dysbiosis
14%
Driveline Infection
14%
Diastolic Blood Pressure
14%
Phage Therapy
14%
Left Ventricular Assist Device
14%
Observational Study
14%
Peritonsillar Abscess
14%
Avibactam Plus Ceftazidime
14%
Creatinine
13%
Proportional Hazards Model
9%
Cystatin C
8%
Morphology
8%
COVID-19 Vaccination
8%
Proteinuria
7%
Osteomyelitis
7%
In Vitro
6%
Hemodialysis
6%
Peritoneal Dialysis
6%
Neutrophil Gelatinase Associated Lipocalin
5%
Debridement
5%
Pathogen
5%